Current Pharmacogenomics and Personalized Medicine
Title:Reviewer Acknowledgement
Volume: 10 Issue: 4
Author(s): Vural Ozdemir
Affiliation:
Export Options
About this article
Cite this article as:
Ozdemir Vural, Reviewer Acknowledgement, Current Pharmacogenomics and Personalized Medicine 2012; 10 (4) . https://dx.doi.org/10.2174/187569212803901774
DOI https://dx.doi.org/10.2174/187569212803901774 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development
Mini-Reviews in Medicinal Chemistry Crosstalk among Jasmonate, Salicylate and Ethylene Signaling Pathways in Plant Disease and Immune Responses
Current Protein & Peptide Science Small Molecule and Biologic Inhibitors of Hepatitis C Virus: A Symbiotic Approach
Mini-Reviews in Medicinal Chemistry A New Cutset-type Kernelled Possibilistic C-means Clustering Segmentation Algorithm Based on SLIC Super-pixels
Journal of Fuzzy Logic and Modeling in Engineering Inhibitors of Cathepsin B
Current Medicinal Chemistry An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Omalizumab: Not Only For Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Monoclonal Antibodies and their Target Specificity Against SARS-CoV-2 Infections: Perspectives and Challenges
Recent Patents on Biotechnology Enoyl ACP Reductase as Effective Target for the Synthesized Novel Antitubercular Drugs: A-State-of-the-Art
Mini-Reviews in Medicinal Chemistry A New Threat to Mankind: COVID 19 - All You Need to Know
Coronaviruses Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
Current Pharmaceutical Design Recent Developments in Oxidative Processes in Steroid Chemistry
Current Organic Chemistry Phytochemical and Pharmacological Investigation of Cassia Siamea Lamk: An Insight
The Natural Products Journal Anticonvulsant Activity Of Benzylamides Of Some Amino Acids And Heterocyclic Acids
Protein & Peptide Letters Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 (ACE2) Receptor
Letters in Drug Design & Discovery Glycogen Phosphorylase Inhibitors
Mini-Reviews in Medicinal Chemistry Design, Synthesis, and Delivery Studies of Organotin(IV) based HCV Inhibitor
Infectious Disorders - Drug Targets Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses
Current Pharmaceutical Design